Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05377840 · ClinicalTrials.gov registry record · NA
Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)
A NA study of Crohn Disease and Ulcerative Colitis (UC), sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT05377840 is a NA study of Crohn Disease and Ulcerative Colitis (UC) that is actively recruiting participants, run by Yale University. The registered enrollment target is 152 participants, below the 203-participant average among 71 other Crohn Disease trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05377840, a NA study of Crohn Disease and Ulcerative Colitis (UC), is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, single center, randomized treatment study to assess if anxiety and depression in participants with IBD can be improved with CBT compared to those treated with SKY.
Conditions Studied
Interventions
- BEHAVIORAL Psychologist-administered Cognitive Behavioral Therapy
- BEHAVIORAL Self-Administered Cognitive Behavioral Therapy
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05377840
The ClinicalTrials.gov registry entry for NCT05377840 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 203-participant average among 71 other Crohn Disease trials with a reported enrollment target (25% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Crohn Disease appearing as the primary indexed condition, and to 2 interventions - of which Psychologist-administered Cognitive Behavioral Therapy is the first listed.
NCT05377840 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05377840 about?
NCT05377840 is a clinical study titled "Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)". This is a prospective, single center, randomized treatment study to assess if anxiety and depression in participants with IBD can be improved with CBT compared to those treated with SKY.
What is the current status of trial NCT05377840?
This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2022-07-05. Estimated completion is 2025-12.
What conditions does trial NCT05377840 study?
This clinical trial studies the following conditions: Crohn Disease, Ulcerative Colitis (UC).
What interventions are being tested in trial NCT05377840?
The interventions under investigation include: Psychologist-administered Cognitive Behavioral Therapy (BEHAVIORAL), Self-Administered Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05377840?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05377840 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
RECRUITING · NA
-
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
RECRUITING · NA
-
Impact of Prebiotics in Ulcerative Colitis
RECRUITING · NA
-
RISE: A Remote Study of Insomnia Treatment in Crohn's Disease
RECRUITING · NA
-
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.